National Institute for Sickness and Disability Insurance (RIZIV/INAMI) has updated the list of non-implantable medical devices for home use

16

May 2018

National Institute for Sickness and Disability Insurance (RIZIV/INAMI) reimburses four types of non-implantable medical devices:

  • reimbursed solutions for bladder irrigation
  • medical care materials accepted for reimbursement:
    • hair prostheses
    • oxygen concentrators
    • pumps and cassettes for medicines
    • inhalation solution of hypertonic sodium chloride for the treatment of cystic fibrosis
    • plaster bands and other plaster material
    • installation and delivery of medical oxygen in gaseous form and accessories
  • diagnostic tools accepted for reimbursement:
    • blood pressure monitors
    • blood glucose meter
    • lancet holder
    • glucose control strips
    • lancets
  • sterile insulin syringes
  • probes for car home

For the first three types of devices (reimbursed solutions for bladder irrigation, medical care materials accepted for reimbursement and diagnostic tools allowed for reimbursement), an official List of the devices eligible for reimbursement is available.

Since May 1, 2018, patients with a type 2 diabetes are eligible for reimbursement of self-management care only if they have or are starting treatment with insulin or incretinomycin.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more